High-level production of diacetyl in a metabolically engineered lactic acid bacterium

Patent metadata

Field	Value
Publication number	US-10563271-B2
Application number	US-201615766461-A
Country	US
Kind code	B2
Filing date	Oct 7, 2016
Priority date	Oct 9, 2015
Publication date	Feb 18, 2020
Grant date	Feb 18, 2020

Abstract

The present invention provides a genetically modified lactic acid bacterium capable of producing diacetyl under aerobic conditions. Additionally the invention provides a method for producing diacetyl using the genetically modified lactic acid bacterium under aerobic conditions in the presence of a source of iron-containing porphyrin and a metal ion selected from Fe 3+ , Fe 2+ and Cu 2+ . The lactic acid bacterium is genetically modified by deletion of those genes in its genome that encode polypeptides having lactate dehydrogenase (E.C 1.1.1.27/E.C.1.1.1.28); α-acetolactate decarboxylase (E.C 4.1.1.5); water-forming NADH oxidase (E.C. 1.6.3.4); phosphotransacetylase (E.C.2.3.1.8) activity; and optionally devoid of or deleted for genes encoding polypeptides having diacetyl reductase ((R)-acetoin forming; EC:1.1.1.303); D-acetoin reductase; butanediol dehydrogenase ((R,R)-butane-2,3-diol forming; E.C. 1.1.1.4/1.1.1.-) and alcohol dehydrogenase (E.C. 1.2.1.10) activity. The invention provides for use of the genetically modified lactic acid bacterium for the production of diacetyl and a food product.

First claim

The invention claimed is:

1. A genetically modified lactic acid bacterium for production of diacetyl, wherein the genome of said lactic acid bacterium is deleted for all of the genes or lacks all of the endogenous genes encoding polypeptides having an enzymatic activity of:
a. lactate dehydrogenase having E.C.1.1.1.27 or E.C.1.1.1.28;
b. α-acetolactate decarboxylase having E.C. 4.1.1.5;
c. phosphotransacetylase having E.C.2.3.1.8;
d. NADH oxidase having E.C. 1.6.3.4;
e. alcohol dehydrogenase having E.C. 1.2.1.10; and
f. a butanediol dehydrogenase having E.C. 1.1.1.4; and
wherein said microorganism is devoid of transgenes encoding polypeptides having an enzymatic activity of:
g. a (S)-acetoin forming diacetyl reductase having E.C.1.1.1.304; and
h. a L-butanediol dehydrogenase having E.C. 1.1.1.76,
wherein the lactic acid bacteria belongs to a genus selected from the group consisting of Lactococcus, Lactobacillus, Pediococcus, Leuconostoc, Streptococcus, Oenococcus , and Bacillus.

2. A genetically modified lactic acid bacterium according to claim 1 , wherein the genome of said lactic acid bacterium is additionally deleted for one or more genes or lacks one or more genes encoding polypeptides having an enzymatic activity selected from the group of:
i. a (R)-acetoin forming diacetyl reductase having E.C.1.1.1.303; and
j. D-acetoin reductase.

3. A genetically modified lactic acid bacterium according to claim 1 , wherein the lactic acid bacteria belongs to the genus Lactococcus.

4. A genetically modified lactic acid bacterium according to claim 1 , wherein:
a. the amino acid sequence of the polypeptide having lactate dehydrogenase activity has at least 80% sequence identity to an amino acid sequence selected from among SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34 and 36.

5. A genetically modified lactic acid bacterium according to claim 1 , wherein:
a. the amino acid sequence of the polypeptide having phosphotransacetylase activity has at least 80% sequence identity to an amino acid sequence selected from among SEQ ID NO: 42, 44, 46, 48, 50, 52, 54, 56, 58 and 60.

6. A genetically modified lactic acid bacterium according to claim 1 , wherein the amino acid sequence of the polypeptide having α-acetolactate decarboxylase activity has at least 80% sequence identity to an amino acid sequence selected from among SEQ ID NO:80, 82, 84, 86, 88, 90, 92, 94 and 96.

7. A genetically modified lactic acid bacterium according to claim 2 , wherein:
a. the amino acid sequence of the polypeptide having alcohol dehydrogenase activity has at least 80% sequence identity to an amino acid sequence selected from among SEQ ID NO: 62, 64, 66, 68, 70, 72, 74, 76 and 78;
b. the amino acid sequence of the polypeptide having diacetyl reductase having E.C.1.1.1.303 activity has at least 80% sequence identity to SEQ ID NO: 98;
c. the amino acid sequence of the polypeptide having D-acetoin reductase activity has at least 80% sequence identity to SEQ ID NO: 100, 102, 104, 106 108, 110 and 112; and
d. the amino acid sequence of the polypeptide having butanediol dehydrogenase having E.C.1.1.1.4 activity has at least 80% sequence identity to SEQ ID NO: 114.

8. A genetically modified lactic acid bacterium according to claim 1 , wherein the amino acid sequence of the polypeptide having a NADH oxidase activity has at least 80% sequence identity to an amino acid sequence selected from among SEQ ID NO: 116, 118, 120, 122, 124, 126, 128, 130, 132, 134 and 136.

9. A genetically modified lactic acid bacterium according to claim 1 , wherein the genome of said lactic acid bacterium comprises genes encoding polypeptides having:
k. lactose-specific phosphotransferase system (PTS) activity having EC 2.7.1.69;
l. phospho-β-D-galactosidase activity having EC 3.2.1.85;
m. galactose-6-phosphate isomerase activity having EC 5.3.1.26;
n. D-tagatose-6-phosphate kinase activity having EC 2.7.1.114; and
o. tagatose 1,6-diphosphate aldolase activity having EC 4.1.2.40.

10. A genetically modified lactic acid bacterium according to claim 9 , wherein:
a. the lactose-specific phosphotransferase system (PTS) activity having EC 2.7.1.69 is provided by a first and a second polypeptide, wherein the amino acid sequence of the first polypeptide has at least 80% sequence identity to an amino acid sequence of SEQ ID NO: 210, and the amino acid sequence of the second polypeptide has at least 80% sequence identity to an amino acid sequence of SEQ ID NO: 212;
b. the amino acid sequence of the polypeptide having phospho-β-D-galactosidase activity having EC 3.2.1.85 has at least 80% sequence identity to an amino acid sequence of SEQ ID NO: 214;
c. the amino acid sequence of the polypeptide having galactose-6-phosphate isomerase activity having EC 5.3.1.26 is provided by a first and a second polypeptide, wherein the amino acid sequence of the first polypeptide has at least 80% sequence identity to an amino acid sequence of SEQ ID NO: 202 and the amino acid sequence of the second polypeptide has at least 80% sequence identity to an amino acid sequence of SEQ ID NO: 204;
d. the amino acid sequence of the polypeptide having D-tagatose-6-phosphate kinase activity having EC 2.7.1.114 has at least 80% sequence identity to an amino acid sequence of SEQ ID NO: 206; and
e. the amino acid sequence of the polypeptide having tagatose 1,6-diphosphate aldolase activity having EC 4.1.2.40 has at least 80% sequence identity to an amino acid sequence of SEQ ID NO: 208.

11. A method for the production of diacetyl, comprising the steps of:
a. introducing a genetically modified lactic acid bacterium according to claim 1 into a growth medium to produce a culture, wherein the growth medium comprises a source of protoporphyrin IX or iron-containing porphyrin;
b. cultivating the culture of (a) under aerobic growth conditions;
c. recovering diacetyl produced by said culture; and optionally
d. isolating the recovered diacetyl.

12. A method for the production of diacetyl according to claim 11 , wherein the source of iron-containing porphyrin is hemin or hematin, wherein the concentration of hemin or hematin is 0.3- 5 μg/ml of the growth medium.

13. A method for the production of diacetyl according to claim 11 , wherein the combined total Fe 2+ , Fe 3+ and Cu 2+ concentration of the growth medium in step (a) is less than 20 mM.

14. A method for the production of diacetyl according to claim 11 , including an additional step of supplementing the culture produced in step (b) with one or more metal ions selected from the group consisting of Fe 2+ , Fe 3+ and Cu 2+ ; and incubating the supplemented culture under aerobic conditions prior to step (c).

15. A method for the production of diacetyl according to claim 11 , wherein the growth medium comprises a source of lactose, such as whey, whey permeate or residual whey permeate.

Assignees

• Univ Danmarks Tekniske

Inventors

• Solem Christian
• Jensen Peter Ruhdal
• Liu Jianming

Classifications

• C12Y401/0204

  Tagatose-bisphosphate aldolase (4.1.2.40) · CPC title

• C12Y207/01069

  Protein-Npi-phosphohistidine-sugar phosphotransferase (2.7.1.69), i.e. sucrose phosphotransferase system II · CPC title

• C12Y101/01027

  L-Lactate dehydrogenase (1.1.1.27) · CPC title

• C12Y503/01026

  Galactose-6-phosphate isomerase (5.3.1.26) · CPC title

• C12Y101/01028

  D-Lactate dehydrogenase (1.1.1.28) · CPC title